ClinVar Genomic variation as it relates to human health
NM_014714.4(IFT140):c.1990G>A (p.Glu664Lys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_014714.4(IFT140):c.1990G>A (p.Glu664Lys)
Variation ID: 31679 Accession: VCV000031679.12
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 16p13.3 16: 1564074 (GRCh38) [ NCBI UCSC ] 16: 1614075 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Dec 15, 2018 Jul 29, 2024 Mar 17, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_014714.4:c.1990G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_055529.2:p.Glu664Lys missense NC_000016.10:g.1564074C>T NC_000016.9:g.1614075C>T NG_032783.1:g.53035G>A Q96RY7:p.Glu664Lys - Protein change
- E664K
- Other names
- -
- Canonical SPDI
- NC_000016.10:1564073:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD), exomes 0.00000
Exome Aggregation Consortium (ExAC) 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00001
The Genome Aggregation Database (gnomAD) 0.00004
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
IFT140 | - | - |
GRCh38 GRCh37 |
1062 | 1915 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Mar 17, 2024 | RCV000024359.19 | |
Pathogenic (1) |
no assertion criteria provided
|
May 4, 2012 | RCV000515561.7 | |
Pathogenic (1) |
criteria provided, single submitter
|
Mar 27, 2021 | RCV001781315.4 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(May 29, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Saldino-Mainzer syndrome
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003272289.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024 |
Comment:
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) … (more)
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on IFT140 protein function. ClinVar contains an entry for this variant (Variation ID: 31679). This missense change has been observed in individual(s) with Mainzer-Saldino syndrome (PMID: 22503633, 31130284, 32860008). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 664 of the IFT140 protein (p.Glu664Lys). Experimental studies have shown that this missense change affects IFT140 function (PMID: 22503633). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Mar 17, 2024)
|
criteria provided, single submitter
Method: research
|
Saldino-Mainzer syndrome
Affected status: unknown
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV004804896.2
First in ClinVar: Mar 30, 2024 Last updated: Apr 06, 2024 |
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Saldino-Mainzer syndrome
Affected status: yes
Allele origin:
germline
|
Centogene AG - the Rare Disease Company
Accession: SCV001426496.1
First in ClinVar: Aug 09, 2020 Last updated: Aug 09, 2020 |
|
|
Pathogenic
(Mar 27, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002023130.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(May 04, 2012)
|
no assertion criteria provided
Method: literature only
|
SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000045652.9
First in ClinVar: Apr 04, 2013 Last updated: Jul 29, 2024 |
Comment on evidence:
Short-Rib Thoracic Dysplasia 9 In a 17-year-old boy with short-rib thoracic dysplasia-9 (SRTD9; 266920) with a clinical diagnosis of Mainzer-Saldino syndrome, who exhibited a small … (more)
Short-Rib Thoracic Dysplasia 9 In a 17-year-old boy with short-rib thoracic dysplasia-9 (SRTD9; 266920) with a clinical diagnosis of Mainzer-Saldino syndrome, who exhibited a small thoracic cavity with short and thick ribs and had early-onset retinal dystrophy and chronic renal failure, Perrault et al. (2012) identified compound heterozygosity for 2 mutations in the IFT140 gene: a 1990G-A transition, resulting in a glu664-to-lys (E664K) substitution at a highly conserved residue, and a G-to-T transversion in intron 19 (2399+1G-T; 614620.0002), predicted to result in the skipping of exon 18. The mutations were detected by ciliome sequencing of the patient's DNA and confirmed by Sanger sequencing; they were not found in 200 control chromosomes. Five affected individuals from 2 additional consanguineous Saudi Arabian families with a clinical diagnosis of Mainzer-Saldino syndrome were found to be homozygous for the E664K mutation. In vitro functional expression studies in retinal pigment epithelial cells demonstrated that the mutant protein had partial to complete loss of basal body localization and an increase of cytoplasmic staining, indicating severe disorganization. Patient fibroblasts showed absent cilia in a high proportion of cells compared to controls, consistent with a defect in ciliogenesis and/or cilia maintenance. Although mutant IFT140 was localized along the cilia axoneme, there appeared to be a defect in retrograde ciliary transport with an abnormal distribution of other ciliary proteins. All patients had onset of retinal dystrophy in infancy with visual loss and nystagmus, and all exhibited skeletal anomalies, including short stature in most, phalangeal cone-shaped epiphyses, and metaphyseal defects in the hips (in 3). In contrast to the compound heterozygous patient, none of the Saudi Arabian patients had overt renal disease and their thorax phenotype was reported to be unremarkable. Four of the 5 Saudi Arabian patients had mild intellectual disability or autistic features with seizures, which may have been due to other factors. Retinitis Pigmentosa 80 In 10 Saudi probands with congenital severe retinopathy (RP80; 617781), including 2 boys previously reported by Khan et al. (2014), Bifari et al. (2016) identified homozygosity for the E664K substitution (c.1990G-A, NM_014714.3) in the IFT140 gene. Some patients exhibited additional features, including developmental delay in 7 of the patients, and cone-shaped phalangeal epiphyses in the 5 who underwent hand x-rays. Noting that all but 1 of the families they studied harbored the E664K mutation, the authors suggested that this represented a founder effect or a mutation hotspot. (less)
|
|
Pathogenic
(May 04, 2012)
|
no assertion criteria provided
Method: literature only
|
RETINITIS PIGMENTOSA 80
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000611639.5
First in ClinVar: Nov 26, 2017 Last updated: Jul 29, 2024 |
Comment on evidence:
Short-Rib Thoracic Dysplasia 9 In a 17-year-old boy with short-rib thoracic dysplasia-9 (SRTD9; 266920) with a clinical diagnosis of Mainzer-Saldino syndrome, who exhibited a small … (more)
Short-Rib Thoracic Dysplasia 9 In a 17-year-old boy with short-rib thoracic dysplasia-9 (SRTD9; 266920) with a clinical diagnosis of Mainzer-Saldino syndrome, who exhibited a small thoracic cavity with short and thick ribs and had early-onset retinal dystrophy and chronic renal failure, Perrault et al. (2012) identified compound heterozygosity for 2 mutations in the IFT140 gene: a 1990G-A transition, resulting in a glu664-to-lys (E664K) substitution at a highly conserved residue, and a G-to-T transversion in intron 19 (2399+1G-T; 614620.0002), predicted to result in the skipping of exon 18. The mutations were detected by ciliome sequencing of the patient's DNA and confirmed by Sanger sequencing; they were not found in 200 control chromosomes. Five affected individuals from 2 additional consanguineous Saudi Arabian families with a clinical diagnosis of Mainzer-Saldino syndrome were found to be homozygous for the E664K mutation. In vitro functional expression studies in retinal pigment epithelial cells demonstrated that the mutant protein had partial to complete loss of basal body localization and an increase of cytoplasmic staining, indicating severe disorganization. Patient fibroblasts showed absent cilia in a high proportion of cells compared to controls, consistent with a defect in ciliogenesis and/or cilia maintenance. Although mutant IFT140 was localized along the cilia axoneme, there appeared to be a defect in retrograde ciliary transport with an abnormal distribution of other ciliary proteins. All patients had onset of retinal dystrophy in infancy with visual loss and nystagmus, and all exhibited skeletal anomalies, including short stature in most, phalangeal cone-shaped epiphyses, and metaphyseal defects in the hips (in 3). In contrast to the compound heterozygous patient, none of the Saudi Arabian patients had overt renal disease and their thorax phenotype was reported to be unremarkable. Four of the 5 Saudi Arabian patients had mild intellectual disability or autistic features with seizures, which may have been due to other factors. Retinitis Pigmentosa 80 In 10 Saudi probands with congenital severe retinopathy (RP80; 617781), including 2 boys previously reported by Khan et al. (2014), Bifari et al. (2016) identified homozygosity for the E664K substitution (c.1990G-A, NM_014714.3) in the IFT140 gene. Some patients exhibited additional features, including developmental delay in 7 of the patients, and cone-shaped phalangeal epiphyses in the 5 who underwent hand x-rays. Noting that all but 1 of the families they studied harbored the E664K mutation, the authors suggested that this represented a founder effect or a mutation hotspot. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort. | Bertoli-Avella AM | European journal of human genetics : EJHG | 2021 | PMID: 32860008 |
Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population. | Monies D | American journal of human genetics | 2019 | PMID: 31130284 |
The ophthalmic phenotype of IFT140-related ciliopathy ranges from isolated to syndromic congenital retinal dystrophy. | Bifari IN | The British journal of ophthalmology | 2016 | PMID: 26359340 |
Early-onset severe retinal dystrophy as the initial presentation of IFT140-related skeletal ciliopathy. | Khan AO | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus | 2014 | PMID: 24698627 |
Mainzer-Saldino syndrome is a ciliopathy caused by IFT140 mutations. | Perrault I | American journal of human genetics | 2012 | PMID: 22503633 |
Text-mined citations for rs387907192 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.